Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial

Journal of Child and Adolescent Psychopharmacology · Published 2026-07-22 · DOI 10.1177/10445463261469764

Authors (4)

Ann Childress, Matthew Brams, Michael J. Cattaneo, Raul Silva

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Childress, A., Brams, M., Cattaneo, M., et al. (2026). Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1177/10445463261469764

Related articles

• Access to Care in Pediatric Acute-Onset Neuropsychiatric Syndrome: A Survey of Families’ Journeys to and Experiences with Intravenous Immunoglobulin Treatment · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Sex-Specific Effects of Relative Fat Mass on Attention-Deficit/Hyperactivity Disorder: Insights from the 1999–2004 National Health and Nutrition Examination Survey · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Clozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Pilot Trial of Adjunctive Curcumin for Treatment-Resistant Bipolar Depression in Youth: Focus on Inflammation and Oxidative Stress · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Letter: Eye Movement Desensitization Reprocessing and Transcranial Magnetic Stimulation in an Adolescent with Comorbid Major Depression Disorder and Posttraumatic Stress Disorder: A Case Report · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• A Retrospective Study of Long-Term Associations of Behavioral Intervention Combined with Medications in Young Children with Attention-Deficit/Hyperactivity Disorder · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Low Emotional Awareness and Altered Frontostriatal Functional Connectivity During Reward Processing Prospectively Predict Depressive Symptoms in At-Risk Youth · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Risperidone Treatment in Children and Adolescents: A Naturalistic Observational Study of Metabolic, Cardiac, and Clinical Outcomes · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal
• Emotional Abuse as an Upstream Factor Influencing Non-Suicidal Self-Injury in Depressed Adolescents: A Network Analysis · Journal of Child and Adolescent Psychopharmacology · 2025 · Same journal
• Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase) · Journal of Child and Adolescent Psychopharmacology · 2026 · Same journal